ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Cancer Atlast Offers New Research Leads

July 17, 1987

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975